GSK position regarding the acquisition of Vectura by Philip Morris International (PMI) - Medical Update Online
Propeller Health, Vectura ink collaborative connected-inhaler deal - MassDevice
Hikma signs agreement with Vectura to commercialize GSK's Ellipta portfolio
GSK ex-CFO swoops for Advair generics-maker Vectura in £958M Carlyle bid | S&P Global Market Intelligence
UK pharma Vectura is latest to work with Propeller on connected inhalers | MobiHealthNews
Track Record - Vectura
Assessing New Technologies in Aerosol Medicine: Strengths and Limitations | Respiratory Care
Court denies GSK appeal in Vectura intellectual property dispute - Sharecast.com
How Much Does Breo Ellipta Cost? - PricePro Pharmacy
Philip Morris takeover of Vectura denounced by COPD Foundation
Vectura names Will Downie as new CEO
VECTURA SIGNS GLOBAL AGREEMENT WITH HIKMA TO DEVELOP GENERIC VERSIONS OF GSK'S ELLIPTA® PORTFOLIO
Hikma and Vectura to Produce Generic Versions of GSK's Ellipta Meds - Pharmaceutical Processing World
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry. - Abstract - Europe PMC
Big tobacco's PMI makes another pharma foray with Vectura deal | pharmaphorum
Hikma and Vectura collaborate to develop GSK generics
Hikma Pharmaceuticals PLC and Vectura Group PLC to develop generic version of GlaxoSmithKline PLC's blockbuster Ellipta inhaler
Vectura prevails in US patent litigation with GSK
Vectura takes £40 million hit as asthma drug fails trial | pharmaphorum
Articles about Vectura Group plc
GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy | Fierce Pharma
Vectura, Hikma team up to develop generic versions of GSK's Ellipta
Vectura agrees $1.4bn takeover by private equity group Carlyle | pharmaphorum
Vectura joins the 'smart inhaler' party with Propeller partnership | Fierce Pharma
